Agenus Inc (NAS:AGEN)
$ 3.105 -0.795 (-20.38%) Market Cap: 66.98 Mil Enterprise Value: 71.28 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 43/100

Q1 2022 Agenus Inc Earnings Call Transcript

May 10, 2022 / 12:30PM GMT
Release Date Price: $32.58 (+9.21%)
Operator

Welcome to Agenus First Quarter 2022 Financial Results Conference Call. My name is James and I'll be your operator for today's call. (Operator Instructions)

And I'd now like to turn the call over to Ethan Lovell, Chief External Affairs and Communications Officer. Mr. Lovell, you may begin.

Ethan Lovell;Chief External Affairs and Communications Officer

Thank you, James, and thank you all for joining us today. Today's call is being webcast and will be available on our website for replay.

I'd like to remind you that this call will contain forward-looking statements, including statements regarding our clinical development, regulatory and commercial plans, and timelines, as well as timelines for data release and partnership opportunities. These statements are subject to risks and uncertainties and we refer you to our SEC filings for more details on these risks.

Joining me today on the call are Dr. Garo Armen, Chairman and Chief Executive Officer; Dr. Steven O'Day, Chief Medical Officer; Dr. Dhan Chand, Head of Drug Discovery

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot